Market Exclusive

Analyst Activity – Mizuho Reiterates Neutral on Mednax (NYSE:MD)

Analyst Ratings For Mednax (NYSE:MD)

Today, Mizuho reiterated its Neutral rating on Mednax (NYSE:MD) with a price target of $48.00.

There are 1 sell rating, 8 hold ratings, 1 buy rating on the stock.

The current consensus rating on Mednax (NYSE:MD) is Hold (Score: 2.00) with a consensus target price of $62.38 per share, a potential 36.46% upside.

Some recent analyst ratings include


Recent Trading Activity for Mednax (NYSE:MD)
Shares of Mednax closed the previous trading session at 45.71 down -1.27 -2.70% with 1,570,903 shares trading hands.

Exit mobile version